ARTICLES BY KEN CONGDON

• Agility & Flexibility To Drive Pharma Manufacturing In 2016

  12/1/2015

  As pharmaceutical manufacturing continues its shift from a volume-based business to being more specialized, pharma companies are attempting to reinvent themselves in this altered, and sometimes unfamiliar, landscape. While many core production objectives remain the same (i.e., bringing new therapies to market, maintaining GMP, ensuring quality assurance, and meeting supply demands), the means by which to accomplish these goals are more multifaceted than ever before. Therefore, as pharmaceutical companies enter 2016, they need to focus on making their operations more agile and flexible.

• Is Pharma Ready For The Mounting Price Transparency Storm?

  5/27/2015

  Perhaps the biggest disruptor in the healthcare industry in recent years has been the concerted effort to bring transparency to the pricing practices that have historically been shrouded in mystery. This initiative came to a head in 2013 when CMS (Centers for Medicare & Medicaid Services) released hospital chargemaster data for the 100 most common DRGs (diagnostic related groups) for 3,400 hospitals.